Available via license: CC BY
Content may be subject to copyright.
Submitted 10 June 2019
Accepted 19 August 2019
Published 4 October 2019
Corresponding author
Abhimanyu S. Ahuja,
aahuja2016@health.fau.edu
Academic editor
Matteo Lambrughi
Additional Information and
Declarations can be found on
page 15
DOI 10.7717/peerj.7702
Copyright
2019 Ahuja
Distributed under
Creative Commons CC-BY 4.0
OPEN ACCESS
The impact of artificial intelligence
in medicine on the future role of the
physician
Abhimanyu S. Ahuja
Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL,
United States of America
ABSTRACT
The practice of medicine is changing with the development of new Artificial Intelligence
(AI) methods of machine learning. Coupled with rapid improvements in computer
processing, these AI-based systems are already improving the accuracy and efficiency
of diagnosis and treatment across various specializations. The increasing focus of AI
in radiology has led to some experts suggesting that someday AI may even replace
radiologists. These suggestions raise the question of whether AI-based systems will
eventually replace physicians in some specializations or will augment the role of
physicians without actually replacing them. To assess the impact on physicians this
research seeks to better understand this technology and how it is transforming medicine.
To that end this paper researches the role of AI-based systems in performing medical
work in specializations including radiology, pathology, ophthalmology, and cardiology.
It concludes that AI-based systems will augment physicians and are unlikely to replace
the traditional physician–patient relationship.
Subjects Ophthalmology, Radiology and Medical Imaging, Human–Computer Interaction, Data
Mining and Machine Learning, Data Science
Keywords Artificial intelligence, Machine learning, Impact, Medicine, Physician, Deep learning,
Radiology, Pathology, Opthalmology, Oncology, Cardiology
INTRODUCTION
The term ‘‘Artificial Intelligence’’ (AI) was first coined by John McCarthy for a conference
on the subject held at Dartmouth in 1956 as ‘‘the science and engineering of making
intelligent machines’’ (Society for the Study of Artificial Intelligence and Simulation of
Behavior, 2018). After a period of reduced funding and interest in AI research, also referred
to as the AI winter (Crevier, 1993), optimism in AI has generally increased since the low
point in the early 1990s. Artificial intelligence (AI) is an important field of computer science
that seeks to create complex machines with characteristics of human intelligence. We can
think of this concept as ‘‘General AI,’’ which has machines that can think and reason
and even see and hear like humans (Copeland, 2016). This concept which can be seen in
movies like Star Wars (think C-3PO, a droid programmed for etiquette and protocol) is not
something we can achieve at this time. However, what is achievable at this time falls under
the concept of ‘‘Narrow AI’’ where technologies exist to perform specific tasks as well as,
or better than, humans can (Copeland, 2016). Examples of such narrow AI include speech
recognition, facial recognition, etc. These technologies exhibit certain facets of human
How to cite this article Ahuja AS. 2019. The impact of artificial intelligence in medicine on the future role of the physician. PeerJ 7:e7702
http://doi.org/10.7717/peerj.7702
intelligence. Such intelligence is derived from AI techniques known as machine learning
and deep learning which have improved performance in areas such as image classification,
text analysis, speech and facial recognition with a range of promising applications such as
autonomous vehicles, natural language processing, and in medicine.
AI is poised to play an increasingly prominent role in medicine and healthcare because
of advances in computing power, learning algorithms, and the availability of large datasets
(big data) sourced from medical records and wearable health monitors. The health care
market for AI is increasing at a rate of 40% and is expected to reach $6.6 billion by 2021
(Frost & Sullivan, 2016). Computing power is increasing rapidly due, in part, to the wide
availability of Graphics Processor Units that make parallel processing even faster and the
availability of seemingly infinite compute resources on demand in the cloud. Big data is
also well supported by practically endless storage in the cloud. Learning algorithms are
becoming more precise and accurate as they interact with training data, allowing newer
insights into diagnostics, treatment options, and patient outcomes (Bresnick, 2018b). The
flood of health care data is helping push the development of new AI applications that
promise to improve the efficiency and effectiveness of patient care. Healthcare related big
data is available from sources such as Electronic Medical Records (EMR) and wearable
health trackers, which can be analyzed in new ways. The rise of AI in the era of big data can
assist physicians in improving the quality of patient care and provide radiologists with tools
for improving the accuracy and efficiency of diagnosis and treatment. AI is well-suited
to handle repetitive work processes, managing large amounts of data, and can provide
another layer of decision support to mitigate errors. The research firm Frost & Sullivan
estimates that AI has the potential to improve patient outcomes by 30% to 40% while
reducing treatment costs by up to 50% (Hsieh, 2017a).
Experts predict AI to have a significant impact in diverse areas of health care such as
chronic disease management and clinical decision making (Bresnick, 2016). While still in
the early stages of adoption, AI algorithms are showing promise in specializations such
radiology, pathology, ophthalmology, and cardiology (Hsieh, 2017a). This progress raises
a thought-provoking question. Will AI at some point displace certain physicians such as
radiologists or will it help make them more effective or will it be a bit of both? This research
looks at the potential uses of AI in medicine and considers the possibility of AI replacing
certain physicians or at least supplementing the role of physicians.
The rest of this paper is organized as follows. A survey of the literature is provided in
‘Literature Survey’. ‘Artificial Intelligence vs. Machine Learning vs. Deep Learning’ provides
a discussion on AI, Machine Leaning, and Deep Learning and how they relate to each other.
‘Promise of AI in Modern Medicine’ discusses the promise of AI in medicine across various
specialties such as radiology, pathology, cardiology, and ophthalmology. ‘Assessing the
Impact of AI on Physicians’ assesses the impact of AI on physicians. Conclusions are
provided in ‘Conclusions’.
Survey methodology
Scholarly articles that were reviewed in this paper were searched in journal databases
such as PubMed and subject-specific professional websites including Google Scholar. The
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 2/19
search terms that were used when searching for articles included artificial intelligence,
medicine, machine learning, deep learning, radiology, pathology, cardiology, oncology,
and ophthalmology. Inclusion criteria for selected articles required that articles be directly
related to the topic on artificial intelligence and medicine. Both qualitative and quantitative
articles were reviewed. Qualitative articles provide insights into the problem by helping
understand reasons, opinions, and motivations. Quantitative articles on the other hand
use measurable data to formulate facts and discover patterns in research.
LITERATURE SURVEY
Patel et al. (2009) present the findings of a panel discussion held at an AI in Medicine
(AIM) conference in 2007 in the Netherlands in a position paper titled, ‘‘The coming of age
of artificial intelligence in medicine’’. The authors reflect on the maturity of AI research
and its impact on the field of medicine and attempt to characterize the influence of AI in
medicine thus far. The authors opine that one indication of the success of AI in medicine is
that AIM methods are becoming more integrated within applications and are not explicitly
visible as such. The question being asked has moved from ‘‘does the system work?’’ to
‘‘does the system also help?’’ and this, according to the authors, indicates that AIM-based
solutions are being implemented in clinical practice (Patel et al., 2009). According to the
authors, machine learning research is becoming more important for the future because
medicine is now a data-rich quantitative field due to the increasing prevalence of Electronic
Medical Records (EMR) and such research is important to make sense of this data and to
create discovery-support systems that support the work of a human physician (Patel et al.,
2009).
King Jr (2018) discusses the impact of AI on the field of radiology. Radiology has
witnessed tremendous strides with the advent of ultrasound, Computed Tomography
(CT), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET)
scanning technologies. The author believes that the next breakthrough will come not
from some new scanner technology but as a courtesy of AI utilizing the imaging data
that is already available from imaging technologies such as ultrasound, CT, MRI, and
PET (King Jr, 2018). According to the author, AI in radiology is likely to appear in stages
with the initial stage already making an appearance. In this first stage AI systems perform
automatic segmentation of various structures within CT and MR images (King Jr, 2018).
This will help isolate and identify pathologic lesions for analysis and will yield significant
savings in time for radiologists (King Jr, 2018).
Recht & Bryan (2017) discuss the impact on radiologists as machine learning/artificial
intelligence is more integrated into clinical practice. According to the authors, AI will
become a routine part of radiologists’ lives and make their work more efficient and accurate
(Recht & Bryan, 2017). Per the authors, it is a possibility within the next 10 years that medical
images will first be pre-analyzed by an AI tool before being reviewed by a radiologist. The
tool would perform routine reading tasks such as quantification, segmentation and pure
pattern recognition (Recht & Bryan, 2017a).
Kruskal et al. (2017) provide a summary of the deliberations at the 38th Radiology
Intersociety Conference held in 2016. The participants discussed applications of machine
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 3/19
learning to image analysis which they consider to be potentially disruptive. Though the
initial reaction of radiologists to the automated interpretation of images may not be
welcoming, the radiologists overall had a sense of optimism about the future of radiology
with the machine learning based technologies augmenting the quality of care (Kruskal
et al., 2017). Radiologists, it was felt, should remain active in the development of these new
technologies by engaging with industry to ensure the ethical usages and clinical relevance
of developing technologies (Kruskal et al., 2017).
Greenspan, Van Ginneken & Summers (2016) focus on technology based on deep
learning as it applies to medical imaging. According to the authors deep learning has
emerged as the leading machine-learning tool in general imaging. Convolutional neural
networks (CNNs) have been shown to be very effective in the field of computer vision
(Greenspan, Van Ginneken & Summers, 2016). Deep CNNs automatically learn mid-level
and high-level abstractions obtained images and recent results show that CNNs are
extremely effective in object recognition and localization in natural images (Greenspan,
Van Ginneken & Summers, 2016).
Quantitative analysis of brain MRI depends on accurate segmentation of structures of
interest. Deep learning algorithms can now be trained with millions of images, in part
due to the rapid increase in Graphical Processing Unit processing power (Akkus et al.,
2017). The authors in Akkus et al. (2017) summarize that while deep learning techniques
in quantitative brain MRI has made big strides, ‘‘it is still challenging to have a generic
method that can deal with all variations in brain MR images from different institutions
and MRI scanners’’.
In the article, ‘‘Your Future Doctor May Not be Human,’’ Norman (2018) postulates that
the role of AI in healthcare is not necessarily about pitting human minds against machine.
Rather, ‘‘AI is in the exam room to expand, sharpen, and at times ease the mind of the
physician so that doctors are able to do the same for their patients’’ (Norman, 2018). The
role of AI in medicine is expanding from diagnostic algorithms to surgical robots. What
is unknown currently is the value of AI in medicine and the author cites several examples
where AI is already just as capable, if not more than capable, as doctors in diagnosing
patients (Norman, 2018). Norman states that AI is perhaps most valuable in medicine
when making sense of huge amounts of data that would quickly overwhelm humans. The
author concludes that the role of AI in medicine isn’t about replacing physicians; rather it
is about optimizing and improving what they already do (Norman, 2018).
Bertalan Meskó, also known as The Medical Futurist, has called AI the ‘‘The Stethoscope
of the 21st Century’’ (Meskó, 2017). According to the author, just as it took time for the
medical community to accept the stethoscope, so it will also take the medical community
time to accept AI as a full-fledged tool for healthcare (Meskó, 2017). Even so, Meskó
predicts that AI will take its rightful place in healthcare with cognitive computers helping
physicians in clinical decision making. In order to make this a reality, Meskó recommends
that physicians should learn how AI works in healthcare, companies such as IBM should
increase awareness in the general public about the advantages and risks of using AI in
medicine, and healthcare institutions should measure the effectiveness of the AI-based
system (Meskó, 2017).
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 4/19
Zaidi (2018) highlights application areas of AI in healthcare that look to be very
promising. One of these areas is cognitive assisted robotics which is considered minimally
invasive whereby large incisions are replaced with a series of quarter-inch incisions and
utilize miniaturized surgical instruments. Furthermore, surgeons integrate the data from
patient pre-op medical records with real-time operating metrics to improve surgical
outcomes (Zaidi, 2018). Case in point is the da Vinci Surgical System which is a surgical
system with robotic limbs which provides a high-definition, magnified, 3-D view of
the surgical site (Zaidi, 2018). It facilitates complex surgery using a minimally invasive
approach and is controlled by a surgeon from a console. On the administrative side of
healthcare, Gohil discusses AI applications that automate non-patient care activities such
as writing chart notes, prescribing medications, ordering tests. Such AI-based systems
that depend on machine learning help healthcare providers cut documentation time and
improve reporting quality (Zaidi, 2018).
Sennaar (2018) discusses the emerging role of AI in the hospital setting. One of the
factors leading to burnout among physicians is managing the growing amounts of clerical
and clinical data and AI applications can help in this regard. One of the risks identified by
the author has to do with data quality. Poor data quality or ‘‘bad data’’ may contribute to
inaccurate clinical data potentially putting patients at risk (Sennaar, 2018). According to
the author, healthcare systems already possessing an effective data collection strategy may
be better suited to implement AI-based applications for data management. The author also
touches upon factors which may cause resistance in the adaptation of AI-based applications.
This includes the limited amount of scientific literature demonstrating the clinical value of
AI applications (Sennaar, 2018).
Houssami et al. (2017) discuss the promise and current reality of AI in breast cancer
(BC) detection. While mammography screening for BC can confer a mortality benefit
through early BC detection, it can also miss a cancer that is present, or can result in
false-positives. To try and improve results mammography screenings have mostly focused
on additional imaging in the form of double instead of single-reading and more frequent
screens (Houssami et al., 2017). Such additional imaging increases resource expenditures.
According to the authors AI can assist mammography screenings become more efficient
by advanced learning using large complex datasets and by performing tasks such as image
interpretation. The authors conclude that while AI is very promising for BC screenings,
to translate this promise into reality requires very large data-sets of imaging examinations
that are associated with clinical factors to train AI models (Houssami et al., 2017).
Another article on BC detection by Trister, Buist & Lee (2017) points out that digital
mammography is an imperfect tool with a sensitivity of 84% for detecting breast cancers.
The other 16% are not detected due to a combination of factors. This has a lot to do with
the human limitation of what radiologists are visually able to identify on mammographic
images (Trister, Buist & Lee, 2017). False positives on the other hand lead to significant
anxiety, biopsies, and unwarranted surgical removal of tissue. The authors report that
critics of screening have suggested that a significant percentage of screen-detected breast
cancers constitute overdiagnosis or cases that would not have become clinically significant
during women’s lifetimes (Trister, Buist & Lee, 2017). Clearly this is an important issue to
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 5/19
women’s health and is an area where AI can help. The authors report that AI algorithms
in digital mammography have converted single whole digital images of the breast into
automatically extracted quantitative, pixel-level variables which are unrecognizable to the
human eye (Trister, Buist & Lee, 2017). Computers can cluster these millions of pixel-level
variables to identify new imaging features associated with BC, which can be associated with
outcome data for training (Trister, Buist & Lee, 2017). The ultimate promise is that AI can
combine these pixel-level variables and associations with patient clinical data, including
any known patient risk factors, to develop predictive algorithms that may someday provide
equal or better accuracy than human screening mammography (Trister, Buist & Lee, 2017).
A Letter to the Editor article in the European Journal of Internal Medicine touches upon
the impact of AI on physicians (Krittanawong, 2018). The author writes that processing
healthcare related big data offers the promise of unlocking new insights and accelerating
breakthroughs in medicine which in turn can help improve clinical practice. It is very
time consuming at present for physicians to analyze big data and requires sophisticated
analytic tools. AI can assist physicians in analyzing such big data and help to improve
the quality of patient care (Krittanawong, 2018). Physicians employ personal medical
histories, physical exams, individual biomarkers, and scores such as CURB-65 (severity
score that estimates mortality of community-acquired pneumonia) to diagnose patients
(Krittanawong, 2018). AI on the other hand can assist physicians by diagnosing diseases
using ‘‘complex algorithms, hundreds of biomarkers, imaging results from millions of
patients, aggregated published clinical research, and thousands of physician’s notes from
EMRs’’ (Krittanawong, 2018).
Liew (2018) discusses the need for the safe implementation of AI systems in radiology,
where radiologists are mandatory as component human authorities. This is referred to as
‘radiologist-in-the-loop’ (Liew, 2018). In this scheme of things radiologists would be needed
to lead multidisciplinary meetings, make judgement calls, and verify reports. According to
the author, machine learning in the form of image processing, computer vision and natural
language processing are the key AI technologies which would augment radiology in the
future (Liew, 2018). The expectation here is that this would lead to a lowering of the overall
cost of imaging to the patient by increasing the productivity of radiologists by automating
time-consuming and low cognitive value tasks.
Roach (2017) looks at some of the applications of AI in Ophthalmology. The most
promising application is in the detection of retinal eye diseases. The author reports that
researchers from the Google Brain project had reported in 2016 that the deep learning
AI system had taught itself to accurately detect diabetic retinopathy (DR) and diabetic
macular edema in fundus photographs (Roach, 2017). AI is also being applied to other
retinal diseases such as age-related macular edema (AMD). According to the article,
AI-based systems are likely to be used by ophthalmologists as just another tool in their tool
set to diagnose eye diseases (Roach, 2017) and to improve the sensitivity to detect patients
at risk and the specificity to correctly identify those without disease.
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 6/19
ARTIFICIAL INTELLIGENCE VS. MACHINE LEARNING VS.
DEEP LEARNING
AI is a subfield of Computer Science that deals with the design and development
of intelligent machines (Society for the Study of Artificial Intelligence and Simulation of
Behavior, 2018). It deals with the use of computers to mimic the cognitive functions of
humans and carry out tasks based on algorithms in an intelligent manner such as learning
from experience, adjusting to new inputs, and performing human-like tasks (Venkatesan,
2018). AI has been used in medicine before. Expert systems, an earlier form of AI, tried
to encode the decisions of physicians into a set of rules that computers could execute
(Schmidt-Erfurth et al., 2018). It was, however, not possible to encode a set of rules for all
clinical situations given the complexity of medicine and variations in diseases. For these
reasons expert systems were replaced in the 1990s by Machine Learning (ML) where the
‘‘rules would be learned by algorithms directly from a set of examples instead of being
encoded by hand’’ (Schmidt-Erfurth et al., 2018).
ML is a subset of AI and emphasizes the learning aspect of intelligence. It has to do with
developing computer programs that can learn and improve from experience without being
explicitly programmed. This stands in contrast to traditional computer programs which
require specific instructions that detail every step the program must take. It would not
be incorrect to say that today when we refer to AI we have almost exclusively ML and its
derivatives in mind. ML research continues to reference the brain as an inspirational source
and attempts to ‘‘imitate the neural structure of the nervous system by creating artificial
neural networks (ANNs) which are networks of units called artificial neurons organized
into layers’’ (Pearson, 2017). The system learns to detect patterns from data provided to
the system in a training session. The ML approach requires that a set of features be directly
measured from the data (e.g., size of breast lesions in CT scans).
A deep neural network (DNN) is an ANN consisting of more layers (usually more than
five) that allows for improved predictions from data. A significant advantage of DNNs is
that their performance continuously improves as the size of the training dataset increases
(Schmidt-Erfurth et al., 2018). This started a new subfield of ML called deep learning which
employs algorithms such as DNN and convolutional neural networks (CNNs). The idea
is ‘‘that a neural network, instead of just acting as a classifier as in the case of classic ML,
can also function as the feature extractor as well’’ (Ahuja & Halperin, 2019). This allows
for end-to-end training because a DNN learns to recognize an output category from the
input signal directly (Schmidt-Erfurth et al., 2018). CNNs are mostly applied to image
segmentation and classification. Graphical Processing Units enable significant acceleration
in the case of CNNs (about 40 times) compared to CPU processing alone (Schmidt-Erfurth
et al., 2018).
PROMISE OF AI IN MODERN MEDICINE
As pointed out earlier, several factors have come together recently to support the quickening
pace of AI developments in medicine (Pratt, 2018). These include the amount of healthcare
data collected in recent years, the high-level computing power at low cost now available
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 7/19
to process large datasets, the increasing prevalence of EMRs, and overall advances in
computing technologies, which have all fueled AI’s advancements in medicine (Pratt,
2018). While AI in medicine is still in its early stages, it is well positioned to make positive
impacts in clinical medicine. As an example, AI could collect and analyze patient data
gathered from multiple sources such as fitness trackers and at-home monitors and enable
physicians to monitor patients’ health in ways that time and resources without AI would
not permit (Pratt, 2018). Some of the specializations in medicine where AI is having a
positive impact include radiology, pathology, ophthalmology, and cardiology. This section
discusses the impact and potential of AI in these specializations.
Diagnostic radiology
AI’s, and specifically ML’s, potential to analyze large datasets and extract meaningful
insights is proving helpful in both radiology and pathology. Images from MRI machines,
CT scanners, and X-rays can contain large amounts of complex data that can be difficult
and time consuming for human providers to evaluate (Kent, 2018). AI/DL technology and
its implementation into day-to-day clinical imaging is poised to transform the practice
of radiology (Liew, 2018). AI can provide clinical decision support to radiologists and
improve the delivery of care to patients. With regard to image processing, DL algorithms
can help select and extract features from medical images as well as help create new features.
With respect to image interpretation, DL algorithms can help identify and classify disease
patterns from images and help the radiologist suggest suitable care pathways for a patient
in consultation with other physicians involved in the care of the patient.
A research study by Lakhani & Sundaram (2017) used DL algorithms in the diagnoses
of tuberculosis (TB) in chest X-ray images and achieved high levels of accuracy. The
researchers obtained 1,007 X-rays of patients with and without active TB. The datasets
were split into training (68.0 percent), validation (17.1 percent), and test (14.9 percent).
The cases were used to train two different deep convolutional neural network (DCNN)
models—AlexNet and GoogLeNet—which learned from TB-positive and TB-negative
X-rays (Lakhani & Sundaram, 2017). The models’ accuracy was tested on 150 cases that
were excluded from the training and validation datasets. The best performing AI model, a
combination of the AlexNet and GoogLeNet, achieved a net accuracy of 96 percent which is
comparable with human radiologists. It is likely that this can be improved with additional
training cases and more advanced deep learning models (Lakhani & Sundaram, 2017).
Kooi et al. (2017) compared a traditional state-of-the art in mammography Computer
Aided Detection (CAD) system which relied on a manually designed feature set with a
DL Convolutional Neural Network (CNN) algorithm to detect breast cancer lesions. Both
systems were trained on a large dataset of approximately 45,000 images and results showed
that the CNN outperformed the traditional CAD system (Kooi et al., 2017). According to
the authors, the system based on DL was shown to perform at the level of a radiologist.
With respect to radiology, AI is poised to automate image segmentation, lesion detection,
measurement, labelling and comparison with historical images (Liew, 2018). The one thing
worth pointing out is that DL, and indeed any ML, algorithms are only as good as the
training sets used to train the system. The quantity and quality of the training set are very
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 8/19
important in the development of state-of-the art DL systems in radiology (Lugo-Fagundo
et al., 2018). In the case of CT scans, this requires the careful annotation of hundreds or
even thousands of images. The creation of well-annotated training sets for this study is
extremely labor intensive (Lugo-Fagundo et al., 2018). The authors in (Lugo-Fagundo et al.,
2018) suggest that institutions develop standard processes and best practice guidelines for
training datasets and share these datasets. Such collaborations would help increase the
number of normal and abnormal datasets available for training DL systems.
Pathology
The field of pathology depends on the trained eye of the pathologist to render a diagnosis
of a biospecimen (Dyche, 2018). Given the many different types and subtypes of a disease
and the avalanche of new data in the form of different biomarkers and genomics data,
this is becoming an increasingly difficult task for the pathologist. In addition, fewer of the
nation’s senior medical students choose to pursue a career in pathology (Dyche, 2018). In
this scenario DL based approaches have a significant role to play. For example, researchers
at Google trained a DL based CNN to assist with the detection of metastatic breast cancer
in lymph node tissue on specimen images with an accuracy comparable to that achieved
by human pathologists (Hsieh, 2017). It is clearly a challenging task to look for very small
deposits of cancer on a specimen slide and a human pathologist can get fatigued, but an
AI-based system suffers from no such problem and can scan any number of specimen slides
with no loss of accuracy due to fatigue. Couple this with the expected amount of big data
in the form of human genomic data, human pathologists will find it nearly impossible for
pathologists to stay current with the emergence of new these biomarkers without the help
of ML (Dyche, 2018).
On a different note, ML has been shown to accurately predict how long a kidney
will function adequately in patients with chronic kidney damage. Specifically, a research
team at Boston University used renal biopsies to train DL based CNN to predict kidney
function. The researchers found that CNN algorithms ‘‘were more precise and accurate
than traditional pathologist-estimated scoring systems when calculating kidney decline’’
(Bresnick, 2018a). Clearly, AI-based systems have the potential to augment clinical decision
making for nephrologists.
Ophthalmology
Many Ophthalmology practices are already using ML and DL to revolutionize vision care.
The immediate impact has been observed in the field of retinal diseases. An AI-based device
has already been FDA approved to detect diabetic retinopathy (FDA News Release, 2018).
Schlegl et al. (2018) developed a deep learning-based system to ‘‘automatically detect and
quantify intraretinal cystoid fluid (IRC) and subretinal fluid (SRF). This system accurately
characterized the pattern of intraretinal fluid in patients with wet AMD or retinal vein
occlusion (RVO) and distinguished between intraretinal cysts and subretinal fluid’’ (Schlegl
et al., 2018). The authors conclude that deep learning in retinal image analysis provides
an accurate means ‘‘for the differential detection of retinal fluid types across the most
prevalent exudative macular diseases and OCT devices’’ (Schlegl et al., 2018).
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 9/19
AI systems are also being used beyond retinal diseases. ‘‘AI systems are being developed
and evaluated to diagnose and grade cataract in pediatric patients based on an analysis of
slit-lamp images (Liu et al., 2017), diagnose glaucoma based on measurement of the retinal
nerve fiber layer (RNFL) thickness and visual field (VF) (Kim, Cho & Oh, 2017), and
diagnose keratoconus based on Scheimpflug tonometry’’ (Ruiz et al., 2017). It is becoming
more important that an ophthalmologist learn about the use of AI.
Cardiology
A research study in the UK showed that ML can improve cardiovascular risk prediction by
correlating complex interactions between risk factors (Weng et al., 2017). The researchers
provided data on 295,000 patients to four ML algorithms (random forest, logistic regression,
gradient boosting machines, neural networks) for training purposes for correlating
medical history with heart attack rates. Next, the algorithms were made to predict which
of additional 82,000 patients would have heart attacks based on their records (Hsieh,
2017;Weng et al., 2017). The best performing ML algorithm, neural networks, accurately
predicted 7.6% more events than the American College of Cardiology/American Heart
Association (ACC/AHA) method with 1.6% fewer false alarms (Hsieh, 2017a). For the
given test sample size of approximately 83,000 records, this correlates to 355 more patients
whose lives could have been saved (Hsieh, 2017a). The authors concluded that ‘‘Machine-
learning significantly improves accuracy of cardiovascular risk prediction, increasing the
number of patients identified who could benefit from preventive treatment, while avoiding
unnecessary treatment of others’’ (Weng et al., 2017).
Another study by Dawes et al. (2017) developed a ML algorithm that enabled them to
predict outcome in patients with pulmonary hypertension with high accuracy. Medical
data from 250 patients were used for the study. According to the authors the ML algorithm
‘‘improved survival prediction independent of conventional risk factors in patients with
newly diagnosed pulmonary hypertension’’ (Dawes et al., 2017).
Looking to the future
While predicting the future of AI in medicine is no easy task it can certainly be said that AI
has a role to play in medicine as a partner. This assessment is based on certain characteristics
of AI-based systems. Systems such as IBM’s Watson can search through millions of pages
of data, read countless medical articles, and far exceed the capacity of any human physician
in its breadth and scale of knowledge (Sappin, 2018). An overworked physician may forget
that a certain patient is vulnerable to a certain drug’s side-effect, but an AI-based system
will not. AI can also assist in surgery in combination with augmented reality programs.
We know that one particular strength of AI-based systems is their ability to gather
and analyze mountains of data and draw conclusions from its analysis. This can help in
predicting disease, which is a challenging task for human physicians in the best of cases. AI
can assist the physician in assessing cancer risk or assessing the risk factors of heart attacks
as compared to strokes (Sappin, 2018). In the foreseeable future physicians could then
help their patients preempt these conditions with a long-term plan of patient care (Sappin,
2018). All these changes are poised to improve the practice of medicine in the future. This
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 10/19
will stem from the practice of medicine becoming more accurate, more comprehensive, and
possibly less expensive over time by preempting diseases, and reducing harmful side-effects,
and unnecessary tests based on patient profile. This is clearly good news for all concerned,
patients, their families, and health care providers.
Transforming medical care
In combination with a human physician AI methods and systems can advance the delivery
of care in a way that outperforms what either can do alone. Consider the case of precision
medicine which seeks to tailor medical treatment to the individual characteristics of a
patient. This is likely to transform the delivery of medical care by enabling physicians to
identify ideal medication dosages, determine which genetic mutations drive certain cancers,
and sequence our microbiome. Central to making precision medicine possible is AI and
ML which can make sense of massive amounts of clinical, genomic, and imaging data,
thus helping to improve physician efficiency, increase diagnostic accuracy, and personalize
treatment.
AI-based systems are poised to increase diagnostic efficiency in other areas of medicine as
well. According to Pearl (2018), such AI-based systems will have a positive impact on various
diagnostic fields including ‘‘radiology (CT, MRI and mammography interpretation),
pathology (microscopic and cytological diagnoses), dermatology (lesion evaluation for
potential melanoma), and ophthalmology (retinal vessel examination to predict the risk
for diabetic retinopathy and cardiovascular disease).’’ According to the American Cancer
Society about half of the women getting annual mammograms over a 10-year period will
have a false-positive finding (American Cancer Society, 2017). False-positive mammograms
can cause anxiety and often lead to unnecessary tests such as MRIs, ultrasounds, and even
invasive biopsies to be sure cancer isn’t there, which cost time and money, and physical
discomfort (Griffiths, 2016).
Another area where AI-based systems are expected to have an impact is in robotic
surgery. Robotic surgery can assist surgeons in treating patients with precision, decreased
blood loss, and less pain (Kakar, 2017). It reduces the possibility of tissue trauma because
the robotic system lowers grasping forces due to tactile feedback and provides the surgeon
with opportunity for remote surgery (Kakar, 2017;Wottawa et al., 2016). Robots enabled
with AI can help reduce surgeon variations that could affect patient recovery.
Wearable healthcare devices (collectively referred to as Healthcare Internet of Things)
from fitness trackers to portable blood pressure and insulin monitors will enable remotely
managed healthcare by directly feeding data not only into individual treatment plans and
EMRs, but also into larger AI-assisted analytics systems (Singh, 2018). This will allow for
at-home management and monitoring of acute conditions, allowing physicians to make
better treatment decisions (Singh, 2018).
Case study: assisting oncologists in India using IBM Watson
IBM’s AI-based Watson for Oncology, a cognitive computing platform trained by Memorial
Sloan-Kettering Cancer Center that analyzes data to identify evidence-based treatment
options, has been adopted by Manipal Hospitals’ corporate and teaching facilities in
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 11/19
India (IBM, 2015). Watson has the ability to read and understand natural language. As of
December 2015, Watson for Oncology had ingested nearly 15 million pages of medical
content, including more than 200 medical textbooks and 300 medical journals (IBM,
2015). Each month Watson ingests about 10,000 new scientific articles and data on 100
new clinical trials to keep up-do-date on new findings (Cavallo, 2017). A note of caution
may be appropriate here. Watson for Oncology treatment recommendations are not based
on its own insights from this data. Instead, they are based on training by physicians of
Memorial Sloan Kettering Hospital who feed Watson information about how patients with
specific characteristics should be treated (Ross & Swetlitz, 2017). Hence, its accuracy and
overall value may be limited by differing medical practices and economic circumstances
(Ross & Swetlitz, 2017). It may be fair to say that Watson for Oncology, while developing
rapidly, is still in its early stage of development (Mearian, 2018).
As of 2015 there were 1 million new cancer cases diagnosed every year in India and
this is expected to rise (IBM, 2015). In addition, India faces a shortage of oncologists,
surgical oncologists and radiation therapists. Given the increasing number of cancer
patients in India, fewer oncologists to treat them, the broad geographic footprint, and
the rapid increase in scientific and clinical knowledge about care, physicians in India
face a challenging time in staying up-to-date about best practices in treatment and care
management. In this scenario, it was hoped that IBM Watson could help physicians in
Manipal hospitals deliver the most advanced, effective, and cost-effective treatment to their
cancer patients. According to a study published by Manipal Hospitals in 2018, Watson
for Oncology was concordant with the hospital’s multidisciplinary tumor board in 93
percent of breast cancer treatment decisions (Somashekhar et al., 2018). However, showing
that Watson agrees with the doctors only shows that it is competent in applying existing
methods of care, not that it can improve them.
AI’s impact on data privacy and ethical concerns
While looking to the future it would be remiss on our part not to assess the impact of
AI on the privacy of medical and patient data. As the use of AI in medicine is increasing
there is a corresponding increase in new threats to the privacy of healthcare related data
(Redmore, 2019). A new study from the University of California, Berkeley suggests that
progress in AI have rendered the privacy standards set by the Health Insurance Portability
and Accountability Act of 1996 (HIPAA) obsolete (Na et al., 2018). It points out that
removing healthcare data of identifying information doesn’t guarantee HIPAA compliance
and this is a matter of concern. Specifically, it is now become possible due to AI to identify
individuals by learning daily patterns from data collected by activity trackers such as
smartwatches and smartphones, and then correlating it to demographic data (Redmore,
2019;Na et al., 2018). Per the authors, ‘‘machine learning successfully reidentified the
physical activity data of most children and adults when using 20-minute data with several
pieces of demographic information’’ (Na et al., 2018). The important conclusion is that
privacy standards associated with the 1996’s HIPAA legislation need to be revisited and
reworked such that the advances of AI and its impact on data privacy as it pertains to
healthcare are factored in (Redmore, 2019;Na et al., 2018).
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 12/19
According to Anil Aswani, lead engineer on UC Berkeley’s privacy study, ‘‘You could
imagine Facebook gathering step data from the app on your smartphone, then buying
health care data from another company and matching the two. Now they would have
health care data that’s matched to names, and they could either start selling advertising
based on that or they could sell the data to others’’ (Redmore, 2019). This opens up a
host of ethical concerns as well. HIPAA does not apply to tech companies that are at the
forefront of advances in AI. It only protects patient healthcare data when it originates from
organizations such as insurance companies and hospitals (Redmore, 2019).
It is reasonable to think that as AI makes it easier for companies to gain access to health
data the likelihood of companies using it in unethical ways also increases. It may become
possible for employers, credit card companies and others to use this AI generated data to
discriminate based on pregnancy or disability status, for instance (Redmore, 2019;Na et al.,
2018). Another potential example is cited in (Redmore, 2019) where genetics companies
are selling customer data to pharmaceutical and biotech firms. The loophole here is that
the service provided by companies of providing ancestry related information from DNA
does not legally count as a healthcare service and so HIPAA privacy rules do not apply
(Redmore, 2019). This opens the door for insurance companies to use use genetics data to
make biased decisions as they pertain to insuring people and prices of insurance policy
premiums (Redmore, 2019).
While AI has very promising applications in the AI field it is up to the users of AI to
address some of these challenges to data privacy and related ethical concerns. We need
to ensure that privacy policies and relevant ethical standards keep pace with the progress
made by AI in medicine. Redmore (2019) makes some recommendations in this regard.
Tech companies need to inform users on exactly how their data will be used and if the
users so desire, they must have the option to decline consent to such use of their data
(Redmore, 2019). Furthermore, tech companies must incorporate technical safeguards into
their AI healthcare solutions to reduce the possibility of misuse and there must be a way to
hold these companies accountable should they fail to do so (Redmore, 2019). Government
must upgade legal frameworks such as HIPAA and/or create new ones as needed (Redmore,
2019).
ASSESSING THE IMPACT OF AI ON PHYSICIANS
In terms of predictive analytics and image recognition, AI may soon become more effective
than physicians, who cannot handle millions of images in any reasonable timeframe.
This has led to some concern that AI-based systems will replace physicians, especially
radiologists. One narrative suggests that AI will interpret even the most complex clinical
images as accurately as today’s most experienced radiologists and eventually replace
radiologists (Pearson, 2017). The contrarian view is that this will not happen; rather AI will
augment radiologists but not replace them (Pearson, 2017). There is yet another middle
of the road view that at some point in the future AI will indeed replace radiologists, but
it is not worth worrying about as that will happen in the distant future (Pearson, 2017).
While it is difficult to project the impact of AI on radiologists in the future, Recht et al.
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 13/19
provide a nuanced opinion in (Recht & Bryan, 2017a) that ‘‘AI will become a routine part of
radiologists’ daily lives, making their work more efficient, accurate, and valuable’’. AI-based
machines will perform routine reading tasks such as quantification and segmentation and
help free up radiologists to ‘‘perform more value-added tasks, such as integrating patients’
clinical and imaging information, having more professional interactions, becoming more
visible to patients and playing a vital role in integrated clinical teams to improve patient
care.’’ (Recht & Bryan, 2017a).
Looking beyond radiologists and considering physicians generally, it seems a reasonable
prediction that AI are likely to augment physicians rather than replace them. There are
several limitations of AI that lead one to this conclusion. AI cannot yet replace doctors at
the bedside, given its limitations. Krittanawong (2018) points out that AI ‘‘cannot engage
in high-level conversation or interaction with patients to gain their trust, reassure them,
or express empathy, all important parts of the doctor–patient relationship.’’ Though one
might speculate that this may change at some point in the future with AI being able to
make a medical conversation. For example, Google demonstrated a phone call of its AI
assistant in their Google I/O 2018 conference.
Physicians are still needed for traditional physical exams, especially in areas such as
neurology, which require high-level patient-physician interaction and critical thinking
(Krittanawong, 2018). Finally, even though AI may reach the point where it can conduct
real-time CT scans or other physical scans, physicians will still be needed for interpretation
in ambiguous and challenging cases. AI-based systems are based on precedence in the case
of ML and DL, but such algorithms can underperform in novel or unusual cases of drug
side effects or treatment resistance where there is no prior example to build on. For these
reasons it can be concluded that AI-based systems will support the skills of physicians and
are unlikely to replace the traditional physician–patient relationship.
CONCLUSIONS
The avalanche of medical data in the form of clinical, genomic, and imaging data is only
likely to accelerate as precision and personalize medicine matures. Consequently, for the
foreseeable future medicine in the future medicine is likely to be even more data-dependent
with the synergy between medicine and AI technology becoming more pronounced. In
recognition of this important trend in modern medicine, medical schools are strengthening
their emerging technology curricula. New courses are being offered by medical schools in
technology infrastructure, ML, DL, and data management alongside their biology classes
(Dyche, 2018).
AI will support the future needs of medicine by analyzing the vast amounts and various
forms of data that patients and healthcare institutions record in every moment. AI is
likely to support and augment physicians by taking away the routine parts of a physician’s
work hopefully enabling the physician to spend more precious time with their patients,
improving the human touch. While AI is unlikely to replace physicians in the foreseeable
future, it is incumbent on medical professionals to learn both the fundamentals of AI
technology as well as how AI-based solutions can help them at work in providing better
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 14/19
outcomes to their patients. Or, it might come to pass that physicians who use AI might
replace physicians who are unable to do so.
ADDITIONAL INFORMATION AND DECLARATIONS
Funding
The author received no funding for this work.
Competing Interests
The author declares there are no competing interests.
Author Contributions
•Abhimanyu S Ahuja conceived and designed the experiments, performed the
experiments, analyzed the data, contributed reagents/materials/analysis tools, prepared
figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.
Data Availability
The following information was supplied regarding data availability:
No raw data or code was generated from this study; this article is a literature review.
REFERENCES
Ahuja AS, Halperin LS. 2019. Understanding the advent of artificial intelligence in
ophthalmology. Journal of Current Ophthalmology 31(2):115–117
DOI 10.1016/j.joco.2019.05.001.
Akkus Z, Galimzianova A, Hoogi A, Rubin D, Erickson B. 2017. Deep learning for brain
MRI segmentation: state of the art and future directions. Journal of Digital Imaging
30(4):449–459 DOI 10.1007/s10278-017-9983-4.
American Cancer Society. 2017. Limitations of Mammograms. American Cancer Society.
Bresnick J. 2016. Big data, artificial intelligence, IoT may change healthcare in 2017.
Available at https:// healthitanalytics.com/ news/ big-data- artificial-intelligence-iot-
may-change-healthcare-in-2017 (accessed on September 2016).
Bresnick J. 2018a. Machine learning, imaging analytics predict kidney function. Available
at https:// healthitanalytics.com/ news/ machine-learning- imaging-analytics-predict-
kidney-function (accessed on January 2018).
Bresnick J. 2018b. Top 12 ways artificial intelligence will impact healthcare. Available at
https:// healthitanalytics.com/ news/ top-12- ways-artificial-intelligence- will-impact-
healthcare.
Cavallo J. 2017. How Watson for oncology is advancing personalized patient care.
Available at https:// www.ascopost.com/ issues/ june-25- 2017/ how-watson-for-
oncology-is-advancing-personalized-patient-care/ (accessed on June 2017).
Copeland M. 2016. What’s the difference between artificial intelligence, machine
learning, and deep learning? Available at https:// blogs.nvidia.com/ blog/ 2016/ 07/ 29/
whats-difference- artificial-intelligence-machine- learning-deep- learning-ai/ .
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 15/19
Crevier D. 1993. AI: the tumultuous search for artificial intelligence. New York: Basic-
Books.
Dawes TJW, De Marvao A, Shi W, Fletcher T, Watson GMJ, Wharton J, Rhodes CJ,
Howard LSGE, Gibbs JSR, Rueckert D, Cook SA, Wilkins MR, O’Regan DP. 2017.
Machine learning of three-dimensional right ventricular motion enables outcome
prediction in pulmonary hypertension: a cardiac MR imaging study. Radiology
283(2):381–390 DOI 10.1148/radiol.2016161315.
Dyche J. 2018. The promise of artificial intelligence in diagnosing illness. Available
at https:// www.cio.com/ article/ 3305951/ the-promise- of-artificial-intelligence- in-
diagnosing-illness.html (accessed on September 2018).
Frost & Sullivan. 2016. From $600 M to $6 billion, artificial intelligence systems poised
for dramatic market expansion in healthcare. Available at https:// ww2.frost.com/
news/ press-releases/ 600- m-6-billion- artificial-intelligence- systems-poised-dramatic-
market-expansion- healthcare/ .
Greenspan H, Van Ginneken B, Summers RM. 2016. Guest editorial deep learning in
medical imaging: overview and future promise of an exciting new technique. IEEE
Transactions on Medical Imaging 35(5):1153–1159 DOI 10.1109/TMI.2016.2553401.
Griffiths S. 2016. This AI software can tell if you’re at risk from cancer before symptoms
appear. Available at https:// www.wired.co.uk/ article/ cancer-risk- ai-mammograms
(accessed on August 2016).
Houssami N, Lee CI, Buist D, Tao D. 2017. Artificial intelligence for breast cancer
screening: Opportunity or hype? The Breast 36(2017):31–33
DOI 10.1016/j.breast.2017.09.003.
Hsieh P. 2017a. AI in medicine: rise of the machines. Available at https:// www.forbes.
com/ sites/ paulhsieh/ 2017/ 04/ 30/ ai-in- medicine-rise-of- the-machines/ (accessed on
April 2017).
IBM. 2015. Manipal hospitals adopts watson for oncology to help physicians identify
options for individualized, evidence-based cancer care across India. Press release.
Available at https:// www.prnewswire.com/ news-releases/ manipal- hospitals-adopts-
watson-for-oncology-to-help-physicians-identify-options-for-individualized-evidence-
based-cancer-care-across-india-300186824.html (accessed on December 2015).
Kakar K. 2017. AI trends that are disrupting healthcare industry. Available at https:
// insights.daffodilsw.com/ blog/ 4-ai- trends-that-are- disrupting-healthcare- industry
(accessed on June 2017).
Kent J. 2018. How artificial intelligence is changing radiology, pathology. Available at
https:// healthitanalytics.com/ news/ how-artificial- intelligence-is-changing- radiology-
pathology (accessed on August 2018).
Kim SJ, Cho KJ, Oh S. 2017. Development of machine learning models for diagnosis of
glaucoma. PLOS ONE 12(5):e0177726 DOI 10.1371/journal.pone.0177726.
King Jr B. 2018. Artificial intelligence and radiology: what will the future hold? Journal of
the American College of Radiology 15(3 Part B):501–503
DOI 10.1016/j.jacr.2017.11.017.
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 16/19
Kooi T, Litjens G, Van Ginneken B, Gubern-Mérida A, Sánchez CI, Mann R,
Den Heeten A, Karssemeijer N. 2017. Large scale deep learning for computer
aided detection of mammographic lesions. Medical Image Analysis 35:303–312
DOI 10.1016/j.media.2016.07.007.
Krittanawong C. 2018. The rise of artificial intelligence and the uncertain future for
physicians. European Journal of Internal Medicine 48:e13–e14
DOI 10.1016/j.ejim.2017.06.017.
Kruskal JB, Berkowitz S, Geis JR, Kim W, Nagy P, Dreyer K. 2017. Big data and
machine learning-strategies for driving this bus: a summary of the 2016 intersociety
summer conference. Journal of American College of Radiologists 14(6):811–817
DOI 10.1016/j.jacr.2017.02.019.
Lakhani P, Sundaram B. 2017. Deep learning at chest radiography: automated classifica-
tion of pulmonary tuberculosis by using convolutional neural networks. Radiology.
Liew C. 2018. The future of radiology augmented with Artificial Intelligence: a strategy
for success. European Journal of Radiology 102:152–156
DOI 10.1016/j.ejrad.2018.03.019.
Liu X, Jiang J, Zhang K, Long E, Cui J, Zhu M, An Y, Zhang J, Liu Z, Lin Z, Li X, Chen J,
Cao Q, Li J, Wu X, Wang D, Lin H. 2017. Localization and diagnosis framework for
pediatric cataracts based on slit-lamp images using deep features of a convolutional
neural network. PLOS ONE 12(3):e0168606 DOI 10.1371/journal.pone.0168606.
Lugo-Fagundo C, Vogelstein B, Yuille A, Fishman EK. 2018. Deep learning in radiology:
now the real work begins. Journal of American College Radiology 15(2):364–367
DOI 10.1016/j.jacr.2017.08.007.
Mearian L. 2018. Did IBM overhype Watson Health’s AI promise? Available at https:
// www.computerworld.com/ article/ 3321138/ did-ibm- put-too-much- stock-in- watson-
health-too-soon.html (accessed on November 2018).
Meskó B. 2017. Artificial intelligence is the stethoscope of the 21st century. Available
at https:// medicalfuturist.com/ ibm-watson- is-the-stethoscope- of-the- 21st-century/
(accessed on July 2017).
Na L, Yang C, Yang C, Lo C, Zhao F, Fukuoka Y, Aswani A. 2018. Feasibility of reiden-
tifying individuals in large national physical activity data sets from which protected
health information has been removed with use of machine learning. JAMA Network
Open 1(8):e186040 DOI 10.1001/jamanetworkopen.2018.6040.
Norman A. 2018. Your future doctor may not be human. this is the rise of AI in
medicine. Available at https:// futurism.com/ ai-medicine- doctor (accessed on January
2018).
Patel VL, Shortliffe EH, Stefanelli M, Szolovits P, Berthold MR, Bellazzi R, Abu-Hanna
A. 2009. The coming of age of artificial intelligence in medicine. Artificial Intelligence
in Medicine 46(1):5–17 DOI 10.1016/j.artmed.2008.07.017.
Pearl R. 2018. Artificial intelligence in healthcare: separating reality from hype. Available
at https:// www.forbes.com/ sites/ robertpearl/ 2018/ 03/ 13/ artificial-intelligence- in-
healthcare/ (accessed on March 2018).
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 17/19
Pearson D. 2017. Artificial intelligence in radiology: the game-changer on everyone’s
mind. Radiology business. Available at https:// www.radiologybusiness.com/ topics/
technology-management/ artificial- intelligence-radiology-game- changer-everyones-
mind.
Pratt MK. 2018. Artificial intelligence in primary care. Medical economics. Available at
https:// www.medicaleconomics.com/ business/ artificial-intelligence- primary-care .
Recht M, Bryan RN. 2017. Artificial intelligence: threat or boon to radiologists? Journal of
American College of Radiologists 14(11):1476–1480 DOI 10.1016/j.jacr.2017.07.007.
Redmore S. 2019. AI in healthcare: data privacy and ethics concerns. Available at https:
// www.lexalytics.com/ lexablog/ ai-healthcare- data-privacy-issues (accessed on April
2019).
Roach L. 2017. Artificial intelligence. Eyenet Magazine 77–83.
Ross C, Swetlitz I. 2017. IBM pitched its Watson supercomputer as a revolution in
cancer care. It’s nowhere close. Available at https:// www.statnews.com/ 2017/ 09/ 05/
watson-ibm-cancer/ (accessed on September 2017).
Ruiz HI, Rozema JJ, Saad A, Gatinel D, Rodriguez P, Zakaria N, Koppen C. 2017. Vali-
dation of an objective keratoconus detection system implemented in a Scheimpflug
tomographer and comparison with other methods. Cornea 36(6):689–695
DOI 10.1097/ICO.0000000000001194.
Sappin E. 2018. 4 ways AI could help shape the future of medicine. Available at https:
// venturebeat.com/ 2018/ 02/ 20/ 4-ways- ai-could-help- shape-the- future-of-medicine/
(accessed on February 2018).
Schlegl T, Waldstein SM, Bogunovic H, Endstraßer F, Sadeghipour A, Philip AM,
Podkowinski D, Gerendas BS, Langs G, Schmidt-Erfurth U. 2018. Fully automated
detection and quantification of macular fluid in OCT using deep learning. Ophthal-
mology 125:549–558 DOI 10.1016/j.ophtha.2017.10.031.
Schmidt-Erfurth U, Sadeghipour A, Gerendas BS, Waldstein SM, Bogunović H. 2018.
Artificial intelligence in retina. Progress in Retinal and Eye Research.
Sennaar K. 2018. Will doctors fear being replaced by AI in the hospital settling. Available
at https:// emerj.com/ ai-sector- overviews/ will-doctors-fear- being-replaced- by-ai-in-
the-hospital-settling/ (accessed on April 2018).
Singh S. 2018. Artificial Intelligence and the internet of things in healthcare. The Journal
of Mhealth. Available at https:// thejournalofmhealth.com/ artificial-intelligence- and-
the-internet-of-things-in-healthcare/ (accessed on April 2018).
Society for the Study of Artificial Intelligence and Simulation of Behavior. 2018. What
is artificial intelligence. Available at https:// aisb.org.uk/ new_site/ ?p=73.
Somashekhar SP, Sepúlveda MJ, Puglielli S, Norden AD, Shortliffe EH, Rohit Ku-
mar C, Rauthan A, Arun Kumar N, Patil P, Rhee K, Ramya Y. 2018. Watson
for Oncology and breast cancer treatment recommendations: agreement with
an expert multidisciplinary tumor board. Annals of Oncology 29(2):418–423
DOI 10.1093/annonc/mdx781.
Trister AD, Buist D, Lee CI. 2017. Will machine learning tip the balance in breast cancer
screening? JAMA Oncology 3(11):1463–1464 DOI 10.1001/jamaoncol.2017.0473.
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 18/19
U.S. Food and Drug Administration. 2018. FDA permits marketing of artificial
intelligence-based device to detect certain diabetes-related eye problems. Available
at https:// www.fda.gov/ news-events/ press- announcements/ fda-permits-marketing-
artificial-intelligence-based-device-detect-certain-diabetes-related-eye.
Venkatesan M. 2018. Artificial intelligence vs. machine learning vs. deep learning.
Data science central. Available at https:// www.datasciencecentral.com/ profiles/ blogs/
artificial-intelligence-vs-machine-learning-vs-deep-learning (accessed on May 2018).
Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. 2017. Can machine-learning improve
cardiovascular risk prediction using routine clinical data? PLOS ONE 12(4):2017.
Wottawa CR, Genovese B, Nowroozi BN, Hart SD, Bisley JW, Grundfest WS,
Dutson EP. 2016. Evaluating tactile feedback in robotic surgery for potential
clinical application using an animal model. Surgical Endoscopy 30(8):3198–3209
DOI 10.1007/s00464-015-4602-2.
Zaidi D. 2018. The 3 most valuable applications of AI in health care. VentureBeat.
Available at https:// venturebeat.com/ 2018/ 04/ 22/ the-3- most-valuable-applications-
of-ai- in-health-care/ .
Ahuja (2019), PeerJ, DOI 10.7717/peerj.7702 19/19
